Erleada
Data Collection & Internet Portals · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 200, Titusville, New Jersey, 0856...Phone Number
(833) 375-3232Website
www.erleada.comRevenue
<$5 MillionIndustry
About Erleada
Is Erleada your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Erleada has new funding data
Congratulate Masked Content for being promoted to Masked Content at Erleada
Click to see if Erleada had a recent Job posting/layoffs
Erleada, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Erleada recently announced quarterly report
Check if Erleada has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Erleada launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Erleada is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Erleada as Masked Content
Find 3 more new buyers
Compare Similar Companies to Erleada
Compare insights from companies similar to Erleada, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Erleada is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
Erleada is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about Erleada.
Erleada Tech Stack
A closer look at the technologies used by Erleada
Erleada News & Media
ERLEADA® (apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence Rates
RARITAN, N.J., Sept. 11, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA) response and strong adherence rates in patients with non-metastatic castration-resistant prostate cancer...
Top Data Collection & Internet Portals Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Erleada
ERLEADA® (apalutamide) is a medication designed for patients requiring treatment for specific conditions. The official patient website provides comprehensive prescribing and safety information. It aims to support patients in understanding their treatment options. The intended clients are individuals seeking information about ERLEADA® and its usage.... Read More